Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms

Journal of Clinical Microbiology

Volumn 46, Issue 7, 2008, Pages 2327-2333

  Snyder, J W ^a,b   Munier, G K ^b   Johnson, C L ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; TETRACYCLINE; TOBRAMYCIN;

ACCURACY; ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CYSTIC FIBROSIS; DISK DIFFUSION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FALSE POSITIVE RESULT; GRAM NEGATIVE BACTERIUM; HUMAN; INTERMETHOD COMPARISON; KLEBSIELLA PNEUMONIAE; LABORATORY; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; ANTIBIOTIC RESISTANCE; AUTOMATION; COMPARATIVE STUDY; DRUG EFFECT; GRAM NEGATIVE INFECTION; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SENSITIVITY AND SPECIFICITY;

BACILLI (CLASS); BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

AUTOMATION; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 49049098877     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00075-08     Document Type: Article

References (20)

1. Brisse, S., S. Stefani, J. Verhoef, A. Van Belkum, P. Vandamme, and W. Goessens. 2002. Comparative evaluation of the BD Phoenix and Vitek 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J. Clin. Microbiol. 40:1743-1748.
2. Carroll, K. C., B. D. Glanz, A. P. Borek, C. Burger, H. S. Bhally, S. Henciak, and D. Flayhart. 2006. Evaluation of the BD Phoenix automated microbiology system for the identification and antimicrobial susceptibility testing of Enterobacteriaceae. J. Clin. Microbiol. 44:3506-3509.
3. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. M100-S15. CLSI, Wayne, PA.
4. Coenye, T., T. Spiker, R. Reik, P. Vandamme, and J. J. LiPuma. 2005. Use of PCR analysis to define the distribution of Ralstonia species recovered from patients with cystic fibrosis. J. Clin. Microbiol. 43:3463-3466.
5. Reference deleted.
6. Elder, B. L., S. A. Hanson, J. A. Kellogg, F. J. Marskik, and R. J. Zabransky. 1997. Cumitech 31, Verification and validation of procedures in the clinical microbiology laboratory. ASM Press, Washington, DC.
7. Endimiani, A., F. Luzzaro, A. Tamborini, G. Lombardi, V. Elia, R. Belloni, and A. Toniolo. 2002. Identification and antimicrobial susceptibility testing of clinical isolates of non-fermenting gram-negative bacteria by the Phoenix automated microbiology system. New Microbiol. 25:323-329.
8. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Caracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.
9. Leverstein-van Hall, M. A., A. C. Fluit, A. Paauw, A. T. A. Box, S. Brisse, and J. Verhoef. 2002. Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 40:3703-3711.
10. Menozzi, M. G., U. Eigner, S. Covan, S. Rossi, P. Somenzi, G. Dettori, C. Chezzi, and A.-M. Fahr. 2006. Two-center collaborative evaluation of performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria. J. Clin. Microbiol. 44:4058-4094.
11. Moland, E. S., N. D. Hanson, J. A. Black, A. Hossain, W. Song, and K. S. Thomson. 2006. Prevalence of newer β-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J. Clin. Microbiol. 44:3318-3324.
12. O'Hara, C. M. 2006. Evaluation of the Phoenix 100 ID/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli. J. Clin. Microbiol. 44:928-993.
13. O'Hara, C. M. 2005. Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli. Clin. Microbiol. Rev. 18:147-162.
14. Sanguinetti, E., B. Posteraaro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanett, and G. Fadda. 2003. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum β-lactamase detection method. J. Clin. Microbiol. 41:1463-1468.
15. Snyder, J. W., G. K. Munier, and C. L. Johnson. 2006. Abstr. 106th Gen. Meet. Am. Soc. Microbiol., abstr. C-016. American Society for Microbiology, Washington, DC.
16. Stefaniuk, E., A. Baraniak, M. Gniadkowski, and W. Hryniewicz. 2003. Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice. Eur. J. Clin. Microbiol. Infect. Dis. 22:479-485.
17. Sturenburg, E., I. Sobottka, H.-H. Feucht, D. Mack, and R. Laufs. 2003. Comparison of BD Phoenix and VITEK 2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella spp. clinical isolates. Diagn. Microbiol. Infect. Dis. 45:29-34.
18. Thomson, K. S., N. E. Cornish, S. G. Hong, K. Hendrick, C. Herdt, and E. S. Molan. 2007. Comparison of Phoenix and VITEK 2 extended-spectrum- β-lactamase detection tests for analysis of Escherichia coli and Klebsiella pneumoniae isolates with well-characterized β-lactamases. J. Clin. Microbiol. 45:2380-2384.
19. van Pelt, C., C. M. Verduin, W. H. F. Goessens, M. C. Vos, B. Tummler, C. Segonds, F. Reubsaet, H. Berbrugh, and A. Van Belkum. 1999. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular tests. J. Clin. Microbiol. 37:2158-2164.
20. Wiegand, L., H. K. Geiss, D. Mack, F. Sturenburg, and H. Seifert. 2007. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J. Clin. Microbiol. 45:1167-1174.